Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $315.6M
Liabilities Breakdown FY2017
Total Liabilities: $79.3M
Asset Breakdown
Total Assets: $315.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $40.3M | 12.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $10.4M | 3.3% |
| Goodwill | $91.0M | 28.8% |
| Intangible Assets | $67.6M | 21.4% |
| Other Assets | $106.4M | 33.7% |
Liabilities Breakdown
Total Liabilities: $79.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 2.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $77.5M | 97.8% |